By staff writers

September 24, 2019 -- The U.S. Food and Drug Administration (FDA) has published draft guidance on how device manufacturers should engage patients when designing medical devices.

The agency's "Patient Engagement in the Design and Conduct of Medical Device Clinical Investigations" draft guidance proposes recommendations for various aspects of design for clinical trials of medical devices. The agency wants to garner direct input from patients as part of the medical device testing process that determines a benefit-risk profile for devices. Comments on the draft guidance will be accepted through November 22.

In a statement, FDA Acting Commissioner Dr. Ned Sharpless noted that the agency values patient experiences with glucose monitors and other devices in the diagnosis and management of common, chronic diseases such as diabetes and end-stage renal disease.

"Patient experiences and insight can help us understand the benefits most important to patients, and what risks patients may or may not be willing to tolerate," he said.

Often, medical device developers collaborate with healthcare providers, clinical researchers, and the FDA to design and test medical devices to understand how products will benefit patients. However, the process usually does not gather input directly from patients, according to Sharpless.

ACLA blasts FDA's 'troubling actions' on pharmacogenetic tests
The American Clinical Laboratory Association (ACLA) has requested a meeting with officials at the U.S. Food and Drug Administration (FDA) regarding the...
Point-of-care testing tackles diabetes risk in Texas
One of the key advantages of point-of-care (POC) testing is the ability to offer test results within a matter of minutes, instead of several hours or...
AMP spells out how labs should report genetic test results
The Association for Molecular Pathology (AMP) has provided guidance on best practices for pharmacogenomic tests, including quality, compliance with CLIA,...
AACC: Labs grapple with 'double-edged sword' of direct-to-consumer testing
ANAHEIM, CA - Direct-to-consumer testing has great potential to get patients engaged about their health and to broaden access to medical information,...

Copyright © 2019

Last Updated np 10/2/2019 3:44:38 PM

Register below for our weekly Letter from the Editor to receive the latest Clinical Lab news and insights.